TrialThe Indian journal of medical research2021

A randomized, double-blind, parallel-group, single-dose comparative pharmacokinetic study of DRL_TZ, a candidate biosimilar of trastuzumab, with Herceptin

Jason D Lickliter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.